Medical Oncologist for GI, NETs & Theranostics. CTO Medical Director @huntsmancancer. NCI NET Task Force Co-Chair. All about collaboration & patient advocacy
Salt Lake City, UT
Joined November 2016
- Tweets1.8K
- Following1.3K
- Followers2.4K
- Likes4.1K
Heloisa Soares MD, PhD, FASCO retweeted
For Dr. @helops79, protecting federal research funding is about supporting the talented researchers & physician-scientists who accelerate the pace of discovery & deliver new options to patients who are counting on the next breakthrough. bit.ly/3TcsKKk #ASCOAdvocacy
Heloisa Soares MD, PhD, FASCO retweeted
My fellow oncologists—join us in Salt Lake City on September 26 for an engaging, discussion-driven forum on the latest and greatest in Neuroendocrine Oncology and GI cancers. Looking forward to exchanging ideas, sharing real-world experiences, and discussing how emerging biomarkers and novel therapies are shaping our practice.
Hope to see many of you there!
@helops79
Heloisa Soares MD, PhD, FASCO retweeted
NANETS is seeking an Association Management Company to serve as our strategic and operational partner.
📅 Proposals due Sept 30, 2026
📄 Full RFP Link ⬇️
docs.google.com/document/d/1…
Please share with organizations that may be a strong fit.
@AmanChauhanMD @OncoThor @HalletJulie @NVijayvergiaMD @marklewismd @UGrewalMD @Jani_Chinmay @NCFCancer @netcanceraware @CureNETs @altoubaht @helops79 @JaydiDelRivero
Heloisa Soares MD, PhD, FASCO retweeted
Calling all who are interested in neuroendocrine tumors!
This is an excellent virtual educational program for patients with NETs, families and caregivers.
And it is free!
Please share with anyone in the NET community who might be interested!
@CureNETs
Education is one of the most powerful tools we have. I hope many of you will take advantage of this outstanding program hosted by NETRF and University of Chicago and share it with anyone in the NET community who may benefit.
This free, virtual event brings together NET experts to discuss the latest advances in diagnosis, treatment, clinical trials, symptom management, and survivorship. It’s also a wonderful opportunity to hear from fellow patients and caregivers and become more informed and empowered throughout your NET journey.
📅 Saturday, July 18, 2026
🕚 11:00 AM – 4:00 PM ET
💻 Free Virtual Conference
Register here:
netrf.org/for-patients/2026-…
@OncoThor @UGrewalMD @ChandrikhaC
Heloisa Soares MD, PhD, FASCO retweeted
Congratulations, Dr. Grewal! 🎉We know you'll bring your #pheo #para #PPGL expertise to the #NETs conversation. Keep up the #PHearless work!
#LetsTalkAboutNets @JaydiDelRivero @helops79 @NANETS1
Honored to serve as co-chair of the NETPact committee @NANETS1 with an amazing leader/mentor @JaydiDelRivero and past-chair @helops79
Looking forward to learning and helping move our collective mission forward 🙏🏽
Heloisa Soares MD, PhD, FASCO retweeted
Thank you to the @utahmammoth for making Saturday’s Hockey Fights Cancer game so meaningful for our staff and patients. Your support and time with our community truly made an impact. #HockeyFightsCancer
Heloisa Soares MD, PhD, FASCO retweeted
We are enrolling these high risk patients on our @SWOG 2104 clinical trial to test the benefit of adjuvant therapy. @helops79 @FlavioRochaMD
This predictive model for NF-PanNETs allows for preoperative risk stratification, which can aid with risk communication, patient counseling, and defining ideal populations for preoperative therapy. journals.lww.com/annalsofsur…
Heloisa Soares MD, PhD, FASCO retweeted
Proud to endorse my mentor and friend @neerajaiims for the @ASCO Nominating Committee! His humility, kindness, unwavering dedication to mentoring young investigators globally & advancing cancer research inspire me every day. A true leader who lifts everyone around him.
Heloisa Soares MD, PhD, FASCO retweeted
Make your voice heard in just a few clicks! The ACT Network simplifies supporting ASCO’s cancer care priorities. Send ready-to-go messages to lawmakers, follow important legislation, and stay up to date on key issues. 👉 Open to all: asco.quorum.us/action_center…
#ASCO #NANETS
Heloisa Soares MD, PhD, FASCO retweeted
Fantastic conversation with @nirmishsingla and @JCensits on the changing landscape in Upper Tract! Excited about this fantastic @SUO_YUO @UroOnc program! Looking forward to more tumor boards with @_backtableUro
In Ep. 16, @nirmishsingla, Dr. Jeannie Hoffman-Censits, and @BogdanaSchmidt discuss treatment for upper tract urothelial carcinoma (UTUC) using evidence-based medicine. #ONC16 @UroOnc @huntsmancancer @HopkinsMedicine @hopkinskimmel @urotoday @ASCO open.spotify.com/episode/2yN…
Heloisa Soares MD, PhD, FASCO retweeted
Great to represent @NANETS1 at the @SWOG meeting in beautiful San Francisco alongside @helops79, @HKennecke, and @AGangiMD.
Two exciting NET concepts were presented—stay tuned for more! It was a pleasure connecting with fantastic colleagues and engaging in meaningful scientific discussions and networking.
Kudos to Drs. Phillip Phillip and Gabi Chiorean for expertly leading the GI section!
@SylvesterCancer
Heloisa Soares MD, PhD, FASCO retweeted
Check out our latest #NETCast podcast where our experts @helops79 @sonbol_bassam & Dr. Shagufta Shaheen dissect results of COMPETE study. @NANETS1 @UAZCancer @UAZHemeOnc @PamelaKunzMD @OncoThor @NVijayvergiaMD @AmanChauhanMD @ChandrikhaC @rachnatshroff
open.spotify.com/episode/4Aa…
Heloisa Soares MD, PhD, FASCO retweeted
Devastating
Federal #kidneycancer research funding drops from $50 million to ZERO after 57% cut to CDMRP. All but 12 of the 35 disease research programs saw funding eliminated for 2025, including the Kidney Cancer Research Program. More about the impact on our blog. bit.ly/4hoXnCq
Heloisa Soares MD, PhD, FASCO retweeted
What about PNETs?
#Pommier principles for resection of PNETs liver metastases at #AHPBA2025
To bookmark 🔖👇🏻
Heloisa Soares MD, PhD, FASCO retweeted
It’s happening! NANETS is in Mexico City with a regional meeting. Dr. Gabriela Buerba kicks it off. Wonderful to connect with colleagues in Mexico. @NANETS1
Heloisa Soares MD, PhD, FASCO retweeted
Today clinic 2 posterchilds clinical trials make difference #pancreaticancer #1 Kras G12D ongoing complete response multi RAS inhibitor trial for 2.5 years (Cycle 40!!). #2 patient with MTAP LOF >1 year on PRMT5 inhibitor. Focus on impactful clinical research @PanCAN @letswinpc
Heloisa Soares MD, PhD, FASCO retweeted
Great discussion from Dr. Wells Messersmith @CUAnschutz on the impact of #BREAKWATER BRAF V600E MT tumor types, the DEEPER trial (JACCRO CC-13), and Checkmate 8HW. #ASCOGI25 @ASCO #colorectal #cancer #cancerresearch
Heloisa Soares MD, PhD, FASCO retweeted
Results of Phase III BREAKWATER for BRAF V600E MT stage IV tx naive pts fulfilled primary endpoint for ORR (61% vs. 40%) and early trend for OS (add'l data to follow) defining a NEW standard of care. #colorectal #cancer @ASCO #ASCOGI25 #colorectal #CancerResearch @NatureMedicine #crcsm @PfizerOncMed @FDAOncology
Heloisa Soares MD, PhD, FASCO retweeted
🙏 @rachnatshroff @AstraZenecaUS @genentech @PfizerOncMed for “Women Excelling in G.I. Oncology”. Packed house! @DocSneakers24 @PamelaKunzMD @kspencer725 @RuthHe12 and Dr. L Goyal. Honored to be included on this panel w/these amazing women! #cancer #cancerresearch #branding was the focus.
Heloisa Soares MD, PhD, FASCO retweeted
🚨 Masterclass on management of colorectal neuroendocrine tumors (well-differentiated) by Dr Jen Chan at #GI25
🌎 rising incidence, primarily driven by rectal NETs
📌 most CR NETs are non functional
‼️Grade, size and depth of invasion are some high risk features pre-resection.
💡 EUS important for staging rectal NETs.
📌 Localized rectal NETs:
-rectal NET/s <10 mm- endoscopic resection
-10-20 mm: Multi-D discussion
->20 mm or LN+ rectal NETs- LAR or APR
-R1 resections are common, consider repeat EUS and multi-D discussion for residual disease management.
📌 Advanced colorectal NETs:
-multi-D eval key!
-If SSTR+, start with SSA (a good test of biology)
-following progression- RLT, mTOR inh, TKIs. CAPTEM for G3
-can consider upfront RLT in Ki67 10-55% in select patients based on NETTER-2
#NETsatGI25 @ASCO
